PL1652843T3 - Pochodne amidu - Google Patents

Pochodne amidu

Info

Publication number
PL1652843T3
PL1652843T3 PL04748296T PL04748296T PL1652843T3 PL 1652843 T3 PL1652843 T3 PL 1652843T3 PL 04748296 T PL04748296 T PL 04748296T PL 04748296 T PL04748296 T PL 04748296T PL 1652843 T3 PL1652843 T3 PL 1652843T3
Authority
PL
Poland
Prior art keywords
amide derivatives
amide
derivatives
Prior art date
Application number
PL04748296T
Other languages
English (en)
Inventor
Toru Kontani
Junji Miyata
Wataru Hamaguchi
Tomoaki Kawano
Akio Kamikawa
Hiroshi Suzuki
Kenji Sudo
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of PL1652843T3 publication Critical patent/PL1652843T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
PL04748296T 2003-08-08 2004-08-05 Pochodne amidu PL1652843T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2003290850 2003-08-08
EP04748296.3A EP1652843B1 (en) 2003-08-08 2004-08-05 Amide derivatives
PCT/JP2004/011573 WO2005014559A1 (ja) 2003-08-08 2004-08-05 アミド誘導体

Publications (1)

Publication Number Publication Date
PL1652843T3 true PL1652843T3 (pl) 2014-09-30

Family

ID=34114142

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04748296T PL1652843T3 (pl) 2003-08-08 2004-08-05 Pochodne amidu

Country Status (19)

Country Link
US (2) US7465748B2 (pl)
EP (1) EP1652843B1 (pl)
JP (1) JP4549974B2 (pl)
KR (1) KR101157074B1 (pl)
CN (1) CN100445271C (pl)
AU (1) AU2004263448B2 (pl)
BR (1) BRPI0413430B8 (pl)
CA (1) CA2535199C (pl)
CY (1) CY1115461T1 (pl)
DK (1) DK1652843T3 (pl)
ES (1) ES2462292T3 (pl)
MX (1) MXPA06001526A (pl)
NO (1) NO335467B1 (pl)
PL (1) PL1652843T3 (pl)
PT (1) PT1652843E (pl)
RU (1) RU2336273C2 (pl)
SI (1) SI1652843T1 (pl)
TW (1) TW200505894A (pl)
WO (1) WO2005014559A1 (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101018318B1 (ko) * 2001-12-21 2011-03-04 노보 노르디스크 에이/에스 Ｇｋ 활성제로서의 아미드 유도체
CA2744893A1 (en) * 2002-06-27 2004-01-08 Novo Nordisk A/S Aryl carbonyl derivatives as glucokinase activators
TW200505894A (en) * 2003-08-08 2005-02-16 Yamanouchi Pharma Co Ltd Tetrahydro-2H-thiopyran-4-carboxamide derivative
BRPI0506662B8 (pt) * 2004-01-06 2021-05-25 Novo Nordisk As compostos ativadores de glucoquinase
WO2006082820A1 (ja) * 2005-02-02 2006-08-10 Astellas Pharma Inc. 性器ヘルペス治療剤
CA2596851A1 (en) * 2005-02-02 2006-08-10 Astellas Pharma Inc. Agent for prevention/treatment of disease caused by acyclovir-resistant herpesvirus
US20090042915A1 (en) * 2005-02-02 2009-02-12 Astellas Pharma Inc. Preventive or therapeutic agent for herpesvirus-releated disease
JP5011739B2 (ja) * 2005-02-03 2012-08-29 アステラス製薬株式会社 テトラヒドロ−２ｈ−チオピラン−４−カルボキサミド誘導体を含有する医薬組成物
JP2009500377A (ja) * 2005-07-08 2009-01-08 ノボ・ノルデイスク・エー／エス ジシクロアルキルウレア型グルコキナーゼ活性化剤
JP2009500378A (ja) * 2005-07-08 2009-01-08 ノボ・ノルデイスク・エー／エス グルコキナーゼ活性化剤としてのジシクロアルキルカルバモイル尿素
JP4960355B2 (ja) * 2005-07-14 2012-06-27 ノボ・ノルデイスク・エー／エス ウレア型グルコキナーゼ活性化剤
JP2010515701A (ja) * 2007-01-09 2010-05-13 ノボ・ノルデイスク・エー／エス ウレアグルコキナーゼアクチベーター
AU2008204530B2 (en) * 2007-01-11 2013-08-01 Vtv Therapeutics Llc Urea glucokinase activators
DE102008014523A1 (de) * 2008-03-15 2009-09-17 Robert Bosch Gmbh Heizgerät
JP5381978B2 (ja) * 2008-04-02 2014-01-08 アステラス製薬株式会社 アミド誘導体含有医薬組成物
ES2518919T3 (es) 2008-05-14 2014-11-05 Astellas Pharma Inc. Derivados del ácido 4-(Indol-7-ilcarbonilaminometil)ciclohexanocarboxílico como antagonistas del receptor EP4 útiles para el tratamiento de la insuficiencia renal crónica o la nefropatía diabética
EP2351565A1 (en) * 2008-10-20 2011-08-03 Astellas Pharma Inc. Medicine for preventing or treating pain related to herpes zoster
CN108623577B (zh) * 2018-05-08 2020-09-25 山东百诺医药股份有限公司 阿莫奈韦及其中间体的制备方法
CA3093025A1 (en) 2018-06-12 2019-12-19 Vtv Therapeutics Llc Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs
WO2020038812A1 (en) * 2018-08-20 2020-02-27 Rijksuniversiteit Groningen New process for the preparation of amenamevir
TW202038947A (zh) 2018-11-28 2020-11-01 德商創新分子有限責任公司 在與溶瘤病毒之組合療法中治療癌症的解旋酶引子酶抑制劑
US12391658B2 (en) 2020-02-18 2025-08-19 Vtv Therapeutics Llc Sulfoxide and sulfone glucokinase activators and methods of use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6288091B1 (en) * 1995-12-29 2001-09-11 Boehringer Ingelheim Ltd. Antiherpes virus compounds and methods for their preparation and use
NZ331104A (en) * 1995-12-29 2000-03-27 Boehringer Ingelheim Ca Ltd Phenyl thiazole derivatives that inhibit herpes replication by inhibiting the herpes helicase primase enzyme complex
AU3289299A (en) * 1998-02-19 1999-09-06 Tularik Inc. Antiviral agents
WO2000029399A1 (en) * 1998-11-12 2000-05-25 Boehringer Ingelheim (Canada) Ltd. Antiherpes compounds
US6500817B1 (en) * 1999-03-08 2002-12-31 Bayer Aktiengesellschaft Thiazolyl urea derivatives and their utilization as antiviral agents
WO2000071511A2 (en) * 1999-05-24 2000-11-30 Cor Therapeutics, Inc. INHIBITORS OF FACTOR Xa
US6545055B1 (en) * 1999-05-24 2003-04-08 Millennium Pharmaceuticals, Inc. Inhibitors of factor Xa
KR20030045180A (ko) * 2000-11-10 2003-06-09 야마노우치세이야쿠 가부시키가이샤 아미드 유도체
DE10139060A1 (de) 2001-08-08 2003-02-20 Merck Patent Gmbh Phenylderivate
WO2003095435A1 (en) 2002-05-09 2003-11-20 Yamanouchi Pharmaceutical Co., Ltd. Amide derivatives
TW200505894A (en) * 2003-08-08 2005-02-16 Yamanouchi Pharma Co Ltd Tetrahydro-2H-thiopyran-4-carboxamide derivative

Also Published As

Publication number Publication date
CA2535199A1 (en) 2005-02-17
EP1652843A4 (en) 2010-07-28
KR101157074B1 (ko) 2012-06-22
CN100445271C (zh) 2008-12-24
US20050032855A1 (en) 2005-02-10
BRPI0413430A (pt) 2006-10-17
CY1115461T1 (el) 2017-01-04
AU2004263448B2 (en) 2009-02-05
US20060229295A1 (en) 2006-10-12
BRPI0413430B8 (pt) 2021-05-25
PT1652843E (pt) 2014-06-02
RU2006106922A (ru) 2006-08-27
US6903125B2 (en) 2005-06-07
AU2004263448A1 (en) 2005-02-17
DK1652843T3 (da) 2014-05-05
BRPI0413430B1 (pt) 2019-04-30
NO335467B1 (no) 2014-12-15
US7465748B2 (en) 2008-12-16
NO20061100L (no) 2006-03-07
EP1652843B1 (en) 2014-04-02
MXPA06001526A (es) 2006-05-25
TWI341311B (pl) 2011-05-01
ES2462292T3 (es) 2014-05-22
KR20060073928A (ko) 2006-06-29
EP1652843A1 (en) 2006-05-03
JPWO2005014559A1 (ja) 2006-10-05
RU2336273C2 (ru) 2008-10-20
JP4549974B2 (ja) 2010-09-22
CA2535199C (en) 2010-12-14
CN1832930A (zh) 2006-09-13
WO2005014559A1 (ja) 2005-02-17
SI1652843T1 (sl) 2014-06-30
TW200505894A (en) 2005-02-16

Similar Documents

Publication Publication Date Title
IL175065A0 (en) Amide derivatives
IL211894A0 (en) Amide derivatives
PL378559A1 (pl) Pochodne piperydynobenzenosulfonoamidu
IL169905A0 (en) Novel 2-pyridinecarboxamide derivatives
GB0317665D0 (en) Qinazoline derivatives
IL183657A0 (en) Amide derivatives
AP1850A (en) Spiroindolineplperidine derivatives
EG24050A (en) Heterocylocarboxamide derivatives
PT1682493E (pt) Derivados de aminoacetonitrilo
IL204829A0 (en) Aniline derivatives
SI1606277T1 (sl) Derivati imidazol-4-il-etinil-piridina
TWI368482B (en) New 2-pyridinylethylbenzamide derivatives
EP1652843A4 (en) amide derivatives
IL176562A0 (en) Amidopyrazole derivative
IL175189A0 (en) N-thiazol-2-yl-benzamide derivatives
GB0329572D0 (en) Amide derivatives
PT1706373E (pt) Derivados de amidoacetonitrilo
AU2003222659A8 (en) 23-o-substituted 5-o-mycaminosyltylonide derivatives
ZA200602131B (en) Amide type carboxamide derivatives
GB2403474B (en) Amide derivatives
GB0312368D0 (en) Novel ureido- and amido-pyrazolone derivatives
AU2003235889A8 (en) Amide derivatives
GB0319793D0 (en) Pyridinylmorpholine derivatives
AU2003243397A8 (en) Homo-camptothecin derivatives
ZA200705150B (en) Amide derivatives